Addressing the Barriers to Pediatric Drug DevelopmentAddressing the Barriers to Pediatric Drug Development
Workshop Summary
Title rated 0 out of 5 stars, based on 0 ratings(0 ratings)
eBook, 2008
Current format, eBook, 2008, , All copies in use.eBook, 2008
Current format, eBook, 2008, , All copies in use. Offered in 0 more formatsDecades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children--50 to 75 percent-- have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.
Title availability
About
Subject and genre
Details
Publication
- Washington, D.C. : National Academies Press, Ă2008.
Opinion
More from the community
Community lists featuring this title
There are no community lists featuring this title
Community contributions
There are no quotations from this title
There are no quotations from this title
From the community